Heart failure and antihypertensive medication

I9_HEARTFAIL_AND_ANTIHYPERT

No definition available.

Endpoint definition

FinnGen phenotype data

429209 individuals

diagram downward connector

Apply sex-specific rule None

429209

diagram downward connector
diagram bullet

Check conditions

RX_ANTIHYP

229781

diagram downward connector

Check pre-conditions, main-only, mode, registry filters None

0 out of 7 registries used, show all original rules.

0

diagram downward connector

Check minimum number of events None

0

diagram downward connector
diagram bullet diagram downward connector

Include endpoints

29130

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

28161

diagram downward connector
I9_HEARTFAIL_AND_ANTIHYPERT

Control definitions

Control conditions not RX_ANTIHYP

Extra metadata

First used in FinnGen datafreeze DF5

Summary Statistics

Key figures

All Female Male
Number of individuals 28161 10336 17825
Unadjusted prevalence (%) 6.84 4.49 9.81
Mean age at first event (years) 69.15 69.32 69.06

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: I9_HEARTFAIL_AND_ANTIHYPERT – Heart failure and antihypertensive medication
GWS hits: 42

Survival analyses between endpoints

Plot

before Heart failure and antihypertensive medication
after Heart failure and antihypertensive medication

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Heart failure and antihypertensive medication

Endpoint not on priority list, no data to show.